<DOC>
	<DOCNO>NCT03102489</DOCNO>
	<brief_summary>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Study BP101 Healthy Volunteers .</brief_summary>
	<brief_title>Safety , Tolerability , Pharmacokinetics Pharmacodynamics Study BP101 Healthy Volunteers</brief_title>
	<detailed_description>Double-blind , randomize , placebo-controlled study safety , tolerability , pharmacokinetics pharmacodynamics BP101 multiple dos administration healthy volunteer .</detailed_description>
	<mesh_term>Sexual Dysfunctions , Psychological</mesh_term>
	<criteria>Healthy woman age 18 40 , inclusive . Verified diagnosis `` healthy '' : absence gastrointestinal , hepatic , renal , cardiovascular , endocrine , central nervous system , ear , nose , throat ( ENT ) gynecological disorder ( perform standard clinical , laboratory instrumental assessment reveal disorder ) . Body mass index ( BMI ) within range 18.5 30 kg/m^2 . Subject consent intake alcohol entire study period ; negative alcohol breath test screen start Investigational Product administration . Negative pregnancy test result screen start Investigational Product administration . Consent use adequate method contraception throughout study . Normal regular menstrual cycle 28 +/ 7 day duration least 6 month study enrollment . Women stable sexual partner . Chronic cardiovascular , respiratory , neuroendocrine , genitourinary system disorder , well gastrointestinal , hepatic , renal , blood , ENT disorder ( include acute chronic rhinitis , sinusitis , others ) . Gynecological disorder ( polycystic ovary syndrome , momma , endometriosis , inflammatory disease others ) . Positive cervical cytology Papanicolaou ( PAP ) test medical anamnesis within 12 month screen . Lab abnormality ( blood hematology biochemistry urinalysis ) screening . Electrocardiogram ( ECG ) abnormalities screen , start Investigational Product administration . Systolic blood pressure sit position 100 mm Hg 140 mm Hg ; and/or diastolic pressure 60 mm Hg 90 mm Hg screen start Investigational Product administration . Heart rate le 60 beats/min 90 beats/min screening , start Investigational Product administration . Signs malignant neoplasms medical history , examination time prior start Investigational Product administration . Psychiatric disorder ( include form schizophrenia , epilepsy , bipolar affective disorder others ) , intake psychotropic agent . Chronic pain syndrome ( include chronic pelvic pain syndrome ) . Acute infection within 4 week screen . Regular intake medication ( include nonprescription drug , vitamin , Supplements ) within 2 week screen . Intake 5 unit alcohol per week ( 1 unit alcohol equivalent 0.5 liter beer , 200 ml wine 30 ml spirit ( pure alcohol ) ) historical information alcoholism , substance abuse , prescription drug abuse . Smoking 10 cigarette day . Pregnancy breastfeeding , positive urine pregnancy screen start Investigational Product administration .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>